November 18, 1:04 PM
Over the past 3 months, 4 analysts have published their opinion on Fulgent Genetics (NASDAQ:FLGT) stock. These analysts…
Raymond James Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $45
November 18, 8:29 AM
Raymond James analyst Andrew Cooper initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $45.
November 7, 5:09 PM
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.05 by 540 percent. This is a 92.1 percent decrease over earnings of $4.05 per share from the